But science is flipping the script. Enter biomarker testing: the art and science of decoding invisible signals pulsing through your veins, breath, and tissue. Today, data-driven health is replacing guesswork with measurable feedback, shaping a world where prevention outpaces reaction.
Think of biomarkers as your body's internal "readout"—tiny molecules revealing whether your organs are humming along or straining. Glucose, cholesterol particles, stress hormones, vitamin levels, inflammation trackers—it's all coded in your blood. Translate the language, and you move from guessing to knowing.
This guide is your passport into that world. You'll learn what biomarkers are, how testing works, why results shift, and what the numbers actually mean. Step by step, we'll explore how biomarkers can spot trouble early, support durable health, and inform longevity without losing sight of the limits.
Ready to read your body's code before trouble arrives? Let's get started.
Key Takeaways
- Biomarkers are measurable signals in blood, urine, saliva, stool, or tissue that help detect, predict, and monitor health and disease.
- Population “normal ranges” are broad; real insight comes from personal trends and context-specific “optimal” zones.
- Results shift with timing, meals, sleep, activity, hydration, or menstrual phase—so consistent testing conditions matter.
- Choose CLIA-certified, CAP-accredited labs for standardized, quality-controlled testing.
- Continuous glucose monitors, multi-omics, and epigenetic clocks now offer deeper, real-time insight into biological aging.
- Focus on patterns, not one-off results—repeat tests under the same conditions and interpret them in full clinical context.
1. What Are Biomarkers?
Picture your bloodstream as a transcript of your health. Each molecule is a line of code narrating what's working, what's wavering, and what's next. Biomarkers are these measurable biological indicators—signals that reflect normal or abnormal processes in your body.
What kinds of signals? Blood sugar (glucose) flags metabolic balance or brewing diabetes risk ¹ ². Cholesterol particles reveal cardiovascular status ³. Cortisol tells a story about stress ⁴ ⁵. Vitamin D measures nutritional sufficiency ⁶. CRP (C-reactive protein) uncovers the simmering flames of chronic inflammation ⁷ ⁸.
And blood is just the beginning. Biomarkers show up in urine (pregnancy, kidney function) ⁹, saliva (stress hormones, sleep markers) ⁴ ⁵, stool (gut balance), breath (metabolism and drug levels), and tissue samples (cancer genes, liver health) ¹⁰.
They're often called "molecular vital signs" because—like blood pressure or temperature—biomarker shifts can flag issues before you feel them. They help detect disease earlier, track progress, and fine-tune longevity and performance strategies for anyone curious enough to turn body signals into action.
2. The Science Behind Biomarker Testing
Here's what actually happens when you get tested.
A sample—often blood, though saliva, urine, or stool are common—is collected and analyzed in a certified laboratory ¹¹ ¹². Instruments quantify hormones (testosterone, thyroid), proteins (CRP, ferritin), enzymes (ALT, GGT), metabolites (glucose, uric acid), and sometimes cells, ions, or genetic variants.
Every report lists a "reference range"—a statistical window derived from screened populations ¹³. But "average" isn't always "optimal." A fasting glucose of 70–99 mg/dL is "normal," yet many people thrive closer to the lower end. That's why some reports now include narrower "optimal" targets tied to better long-term outcomes.
Results fluctuate with physiology. Circadian rhythms swing hormones like cortisol and testosterone ¹⁴ ¹⁵. Hydration changes concentration. Meals, exercise, medications, stress, and—in women—cycle phase or menopause can shift values ¹⁶. Numbers move because biology moves.
How do labs detect molecules? Immunoassays act like lock-and-key antibody systems (fast, cost-effective). Chromatography separates molecules by size or charge (think sorting on a conveyor). Mass spectrometry weighs and identifies compounds with high precision—molecular detective work. Fasting improves reproducibility by reducing post-meal variability, and reference ranges are set using large datasets and statistical methods ¹³.
Preparation and handling can influence results; for the practical details on fasting, timing, shipping, and stability, see Section 7.
3. Why Biomarkers Matter
Biomarkers bridge the gap between silent physiology and actionable decisions.
Consider ApoB, which can predict atherosclerotic risk decades before symptoms ¹⁷ ¹⁸. High-sensitivity CRP detects low-grade inflammation that quietly raises vascular risk ⁷ ⁸ ¹⁹. These markers give you a head start: instead of waiting for crisis, you map where you're headed and intervene earlier. Subtle shifts often precede diagnosis by years.
Beyond disease, biomarker panels inform longevity by illuminating biological age versus calendar age ²⁰ ²¹, metabolic flexibility (how gracefully you handle a glucose load), and resilience (how you bounce back from stress or illness). Track the right markers over time and you don't just see the present—you glimpse the trajectory. In that sense, biomarkers can feel like a time machine for your health.
4. Categories of Biomarkers
Every marker on this list is a thread in your body's grand tapestry—pull one, and you tug at the others.
Metabolic Biomarkers
Metabolic markers are the heartbeat of modern health tracking. The big players—glucose, insulin, HbA1c, triglycerides, lipids—map how your body makes and spends energy ¹ ². Fasting glucose and HbA1c flag early prediabetes, sometimes years before you feel "off." Consistently high insulin means your cells are tuning out the hormone's signal—a classic red flag for insulin resistance and its metabolic sidekicks: fatty liver, abdominal obesity, and sluggish mitochondria ² ²².
What changes these numbers? Movement is a glucose sink—muscle contraction lowers blood sugar by hoovering up glucose without insulin. Nutrition designs the playing field. Swapping refined carbs for fiber tightens glucose swings. High triglycerides? That's often a sign your liver is dumping unused fat into circulation, sometimes a clue for excess calories, lack of activity, or genetics at work.
Cardiovascular Biomarkers
The stars here: LDL-C ("bad cholesterol"), HDL-C ("good cholesterol"), ApoB (a clearer risk measure than LDL), Lp(a) (a pesky genetic wild card), and hs-CRP (inflammation's calling card). ApoB counts the actual number of atherogenic particles; higher numbers out-predict LDL for artery plaque long-term ¹⁷ ¹⁸ ²³. Lp(a) rides in families and shrugs off most lifestyle tricks, raising risk for heart disease and stroke.
Inflammation? That's where hs-CRP enters. Even mild elevation spells trouble for the blood vessels, foreshadowing higher risk even in people with perfect cholesterol ⁷ ⁸ ¹⁹. Factor in genetics and lifestyle—some produce more cholesterol, others just store more in arteries.
Hormonal Biomarkers
Think of hormones as the orchestra conductors of the body. Thyroid hormones (TSH, free T4, free T3) control every cell's energy pace ¹⁴ ²⁴. Testosterone, estradiol, and progesterone steer puberty, libido, muscle gain, sleep, and mood ¹⁵ ²⁵. Cortisol is your "go" signal—high in the morning, easing as night falls ⁴ ⁵. But context matters: women's sex hormones dance through cycles, pregnancy, and menopause. "Optimal" looks different at 25 versus 65, or for a male vs. female, or for someone on medications.
Sluggish thyroid? Brain fog, weight gain, and cold hands. High cortisol? Poor sleep, "wired but tired," and belly fat. These markers reveal why endless fatigue or mood swings aren't "just personality."
Inflammation & Immune Markers
Here come the fire-chasers. CRP rises with injury or infection, but if it stays up when you're well, suspect silent inflammation—often from obesity, metabolic syndrome, or hidden autoimmune storms ⁷ ⁸. Ferritin stores iron, but also spikes with inflammation ²⁶ ²⁷. Cytokines (like IL-6) dial up or down the immune system's force field. WBC (white blood cell) differentials drill deeper: neutrophils mean bacterial action, lymphocytes hint viral, eosinophils shout allergy.
Acute inflammation is your body's firefighter—short, sharp, and lifesaving. Chronic, low-grade inflammation quietly erodes the system, predisposing to diabetes, dementia, and vascular aging.
Nutrient Biomarkers
Vitamin D, B12, folate, ferritin (iron store), magnesium, and zinc measure not just intake but absorption, transport, and storage ⁶ ²⁶ ²⁷. Deficiency? Sometimes it's low intake or sun exposure (for vitamin D), sometimes gut absorption fails (B12, iron), sometimes competition from medications or underlying disease.
Ever wonder why low iron lingers despite a perfect diet? It can be chronic inflammation, blood loss, or absorption issues. Magnesium and zinc can vanish quietly too, especially with high stress, intense sweat, or certain drugs.
Liver, Kidney, and Detox Markers
ALT, AST, GGT, and bilirubin are your liver's dashboard ²⁸ ²⁹. Elevated ALT/AST means possible injury—viral hepatitis, fatty liver, or medication effects. GGT loves a high alcohol diet (but also flags oxidative stress). Bilirubin rises with bile flow problems.
Creatinine and eGFR tell your kidneys' filtration tale ³⁰ ³¹. High creatinine can mean reduced function, while low eGFR sets off alarms for chronic kidney disease. These markers flag how well you clear waste, metabolize hormones, and process toxins from food, drugs, and the environment.
Cellular & Aging Biomarkers
Dive deeper and you find homocysteine (a byproduct linked to heart and brain health) ³² ³³, uric acid (traditionally tied to gout, now known to affect metabolism), oxidative stress markers (is your body winning or losing the battle against cell damage?), and—yes—telomere length (your chromosomes' "shoelace tips") ³⁴ ³⁵ ³⁶. Short telomeres and high homocysteine both flag higher biological age than calendar age. They tie into cardiovascular resilience, neurodegeneration, and aging speed.
5. Types of Biomarker Tests
Not all tests are created equal. What's measured is only half the story—how it's measured matters too.
In-Lab Testing (Traditional Clinical Testing)
Venipuncture (a blood draw from your arm) is the gold standard. It allows for high-volume testing—hundreds of markers from a few tubes—processed in accredited labs with robotic precision and rigorous controls. The advantages? Accuracy, thoroughness, and robust quality control ³⁷ ³⁸.
But convenience is the flip side. In-lab tests require scheduling, travel, and often insurance or higher costs. Results arrive in days, sometimes longer if complex analysis is required.
At-Home Testing (Self-Collection Kits)
Here's where biomarker testing meets the Amazon generation. Finger-prick blood spots, saliva swabs, and urine cups let you collect samples at home. Drop them in the mail, and they end up in certified labs for analysis. The good: privacy, less disruption, and wider access. The trade-off? Your sample volume is tinier, so the marker range shrinks, and results can vary a bit more. Not all tests are cleared for at-home sampling—some markers (like potassium or hormone timing) need full venipuncture or precise collection.
Hybrid & Continuous Models
Digital-first clinics and remote ordering platforms blend the best of both worlds—at-home collection, professional draw options, and cloud-based dashboards. Meanwhile, continuous biomarker monitoring (like CGMs for glucose ³⁹ ⁴⁰ or wearables tracking sweat electrolytes) now gives real-time feedback—no lab required.
Lab Certification and Quality Assurance
When choosing where to test, certification matters. In the United States, clinical labs must be CLIA-certified (Clinical Laboratory Improvement Amendments)—a federal standard ensuring basic quality and accuracy ³⁷ ⁴¹. Many top labs go further, earning CAP accreditation (College of American Pathologists) ³⁸ ⁴², which adds stricter quality checks, regular inspections, and peer review by other lab professionals.
So what does this mean for you? CLIA and CAP certifications ensure the lab follows standardized procedures, participates in proficiency testing (where labs are checked against known samples), and maintains equipment properly. When comparing testing companies, look for these credentials—they're your assurance that results are reliable and reproducible.
6. How Biomarker Results Are Interpreted
Your lab report compares results to a reference range—a population snapshot—not a personal target ¹³. "Optimal" ranges are narrower zones associated with better outcomes, and context determines what's right for you: age, sex, genetics, medications, lifestyle, and life stage all shape interpretation. For example, a fasting glucose of 99 mg/dL may be "normal," but if your personal pattern was 85 last year, the trend—not the single value—matters. Low-normal testosterone may be acceptable for an older adult yet suboptimal for a symptomatic younger adult.
The most powerful insight comes from longitudinal data. Establish your personal baseline, repeat testing under comparable conditions, and watch the direction of change. Once you can see the pattern, the next question is how to act on it.
7. How to Prepare for Biomarker Testing
Set yourself up for clarity, not confusion.
For tests involving glucose, insulin, and many lipid panels, fasting for 8–12 hours (water only) reduces post-meal variability. Morning draws help standardize circadian effects, since hormones and metabolites follow daily rhythms ¹⁴. In the 24 hours before testing, strenuous exercise, alcohol, high-dose supplements, and sometimes even large caffeine intakes can skew values. Hydration matters: being under-hydrated can falsely concentrate some analytes.
For women, timing reproductive and fertility markers to specific cycle windows improves interpretability; perimenopause and menopause require their own timing considerations ¹⁶. Medications and acute illness should be disclosed and, when appropriate, stabilized before comparative testing.
What happens between the stick and the analyzer is equally important. Pre-analytical handling—collection tubes, mixing, time to centrifugation, temperature during transport, and avoidance of hemolysis—materially affects stability and accuracy ³⁷ ³⁸. Certified labs follow strict protocols (rapid processing, controlled storage, proficiency checks) to minimize error. If you're using an at-home kit, follow instructions precisely, ship promptly, and avoid temperature extremes so your sample reflects your true physiology.
Consistency across draws—same time of day, similar sleep and stress levels, and even, if possible, the same season—turns snapshots into a reliable time-lapse.
8. How Often Should You Test?
Cadence depends on goals, risk, and context.
- Many healthy adults benefit from an annual baseline to establish a personal reference point.
- Individuals optimizing performance, fine-tuning nutrition, or adjusting therapy often retest every 3–6 months to capture trend direction.
- During acute illness, recovery, medication changes, or chronic disease management, shorter testing intervals may be appropriate.
Health is dynamic. One number once is like managing finances from a single bank statement. If you're largely sedentary with stable habits, annual testing may suffice. If you're changing your diet, training, or addressing symptoms, more frequent checks convert before-and-after snapshots into a meaningful trajectory. Athletes may test monthly; recreationally active people often do well with one to two focused panels per year.
9. The Evolution of Biomarker Testing
"Chem panels" once measured a handful of electrolytes and lipids. Now, multi-omic approaches integrate genomics (what you're born with), proteomics (real-time protein activity) ⁴³ ⁴⁴, metabolomics (chemical fingerprints) ⁴³ ⁴⁴, and microbiomics (gut ecology). Machine learning models increasingly connect patterns across these layers to estimate risk and biological age ²⁰ ²¹ ⁴⁵.
Continuous monitoring from wearables—glucose, heart-rate variability, sleep metrics—adds a dynamic stream between lab draws ³⁹ ⁴⁰. The promise is more personalized, predictive care; the responsibility is safeguarding privacy and using data constructively. Frameworks like HIPAA and informed-consent practices matter as datasets become richer and more personal.
The trend line is clear: more data, measured more often, interpreted more intelligently.
10. From Data to Action
Testing provides information, not instructions—and that's its power. Combine objective numbers with clinical context and lived experience to make better decisions. If ApoB was elevated six months ago and you adjust diet, activity, or therapy, retesting shows whether the change moved the physiology you care about ¹⁷ ¹⁸. That feedback loop is prevention in action.
Avoid over-reacting to isolated outliers. Pattern recognition beats one-off results, especially when you standardize timing and conditions. Collaboration with experienced clinicians accelerates the process: they integrate symptoms, history, and multiple markers and have seen the common arcs—and the exceptions—many times.
A simple vignette makes it concrete: a 42-year-old with rising ApoB shifts dietary sources of fat, adds soluble fiber, and rechecks in six months; ApoB drops and hs-CRP calms. The story isn't the lab printout—it's the change the data helped catalyze.
11. Limitations of Biomarker Testing
Let's get real—no test is perfect, and biomarkers aren't crystal balls. They offer probabilities, not certainties, and even the best data needs context.
Here's what can shape or skew results:
- Assay and instrument differences: Labs use different equipment and methodologies, which can produce small but meaningful shifts in values.
- Biological variability: Hydration, stress, sleep, illness, or menstrual phase can change numbers from one day to the next ¹⁶.
- Pre-analytical factors: Sample handling—temperature, timing, or tube type—can alter stability and accuracy ³⁷.
- Inter-lab inconsistency: Using different labs for repeat tests can make it hard to see true trends.
- False positives and negatives: Tests sometimes flag problems that aren't there—or miss those that are—especially when screening rare conditions in low-risk people.
- Cost and accessibility: Insurance rules, test pricing, and regional availability still limit how often or how broadly many people can test.
The takeaway? Biomarkers are best used as guides, not verdicts. The real power comes from repeating tests under consistent conditions and interpreting results in the context of your own history, symptoms, and goals.
Turn Insight Into Longevity With Superpower
Every molecule tells a story. When you measure them together, those stories reveal the full picture: how your metabolism, hormones, inflammation, and resilience are actually performing. That’s where real prevention begins: not in guesswork, but in data you can act on.
Here’s the truth: longevity isn’t about hacking one number. It’s about pattern recognition, tracking how your systems move, recover, and adapt over time. Biomarker testing turns biology into feedback and feedback into power — and that’s exactly what Superpower was built for.
Superpower brings over 100 biomarkers into a single, integrated panel so you don’t have to bounce between fragmented tests or wonder what’s missing. Your results live in one dashboard, interpreted through real clinical insight and explained in clear, human language. It’s not just lab work; it’s a full-body feedback loop designed to help you stay ahead of disease, optimize performance, and track your biological age as you evolve.
Whether you’re chasing sharper focus, better energy, or a longer healthspan, the smartest move is to start measuring. You can’t change what you don’t track, and with Superpower, tracking becomes transformation.
Your data is waiting. Your body’s talking. It’s time to see how Superpower can help you listen.
Footnotes
- Sung, J.Y., et al. (2015). "Glycated Hemoglobin, Fasting Insulin and the Metabolic Syndrome: Associations with Metabolic Traits." PLOS ONE.
- Zhu, Y., et al. (2025). "Exploring Essential Biomarkers Linked to Metabolic Dysfunction." Nutrients.
- Brunzell, J.D., et al. (2011). "A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk." Circulation: Cardiovascular Quality and Outcomes.
- Yaribeygi, H., et al. (2021). "Physiological biomarkers of chronic stress: A systematic review." PLoS ONE.
- Ivković, M., et al. (2019). "Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values." Frontiers in Molecular Biosciences.
- Bouillon, R., et al. (2024). "Consensus Statement on Vitamin D Status Assessment and Supplementation." Endocrine Reviews.
- Calabrò, P., et al. (2020). "Changes in C-reactive protein in response to anti-inflammatory drugs and incidence of major adverse cardiovascular events: a meta-analysis." Heart.
- Ridker, P.M., et al. (2024). "High-sensitivity C-reactive Protein in Atherosclerotic Cardiovascular Disease: Measure or Not?" U.S. Cardiology Review.
- Siddiqui, K., et al. (2022). "A systematic review with meta-analysis of biomarkers for detection of pulmonary arterial hypertension." European Respiratory Review.
- Shi, H., et al. (2023). "Comparison of different predictive biomarker testing assays for PD-1/PD-L1 checkpoint inhibitors response: a systematic review and network meta-analysis." Frontiers in Immunology.
- Thurnham, D.I., et al. (2017). "Adjusting ferritin concentrations for inflammation: Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project." The American Journal of Clinical Nutrition.
- Inker, L.A., et al. (2015). "Biomarkers in chronic kidney disease, from kidney function to kidney damage." World Journal of Nephrology.
- Liu, W., Bretz, F., Cortina-Borja, M. (2021). "Reference range: Which statistical intervals to use?" Statistical Methods in Medical Research.
- Arlt, W., et al. (2019). "Physiology, Thyroid Stimulating Hormone." StatPearls. NCBI Bookshelf.
- Barbonetti, A., et al. (2024). "Metabolic benefits afforded by estradiol and testosterone in both sexes: clinical insights." Communications Biology.
- Welt, C.K., McNicholl, D.J. (2020). "Pitfalls of HbA1c in the Diagnosis of Diabetes." Journal of Clinical Endocrinology & Metabolism.
- Brunzell, J.D., et al. (2011). "A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk." Circulation: Cardiovascular Quality and Outcomes.
- Ference, B.A., et al. (2024). "Discordance among apoB, non–high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol." European Heart Journal.
- Ridker, P.M. (2024). "High-sensitivity C-reactive protein in atherosclerotic cardiovascular disease." U.S. Cardiology Review.
- Horvath, S., Raj, K. (2022). "The relationship between epigenetic age and the hallmarks of aging in human cells." Nature Aging.
- Chen, L., et al. (2022). "Epigenetic clock: A promising biomarker and practical tool in aging." Mechanisms of Ageing and Development.
- Marshall, S., et al. (2023). "Hyperinsulinemia: an early biomarker of metabolic dysfunction." Frontiers in Clinical Diabetes and Healthcare.
- Sniderman, A.D., et al. (2024). "APOLIPOPROTEIN B: Bridging the gap between evidence and clinical application." Journal of Clinical Lipidology.
- Mullur, R., Liu, Y.Y., Brent, G.A. (2014). "Thyroid Hormone Regulation of Metabolism." Physiological Reviews.
- Traish, A.M. (2024). "Testosterone / Estradiol Ratio (T:E2) biomarker." Superpower Health.
- Thurnham, D.I., et al. (2017). "Adjusting ferritin concentrations for inflammation." The American Journal of Clinical Nutrition.
- Kell, D.B., Pretorius, E. (2014). "Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells." Metallomics.
- Kim, W.R., et al. (2016). "The past and present of serum aminotransferases and the future of liver chemistry." Clinics in Liver Disease.
- Liu, Z., et al. (2021). "Abnormal liver enzymes: A review for clinicians."
- Inker, L.A., et al. (2015). "Biomarkers in chronic kidney disease, from kidney function to kidney damage." World Journal of Nephrology.
- Delgado, C., et al. (2024). "Bias and Accuracy of Glomerular Filtration Rate Estimating Equations: A Systematic Review and Meta-analysis." JAMA Network Open.
- Fan, R., et al. (2014). "Elevated homocysteine levels and risk of cardiovascular and all-cause mortality: a meta-analysis of prospective studies." Journal of Zhejiang University Science B.
- Clarke, R., et al. (2002). "Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis." JAMA.
- Vaiserman, A., Krasnienkov, D. (2021). "Telomere Length as a Marker of Biological Age: State-of-the-Art, Open Issues, and Future Perspectives." Frontiers in Genetics.
- Sanders, J.L., Newman, A.B. (2013). "Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither?" Epidemiologic Reviews.
- D'Mello, M.J.J., et al. (2015). "Is Telomere Length a Biomarker of Aging? A Review." The Journals of Gerontology: Series A.
- Centers for Disease Control and Prevention (CDC). (2025). "Clinical Laboratory Improvement Amendments (CLIA)."
- College of American Pathologists (CAP). (2020). "Laboratory Accreditation Program."
- Bailey, T., Grunberger, G., et al. (2016). "Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities." Diabetes Technology & Therapeutics.
- Zhu, L., et al. (2024). "Efficacy and Safety of Continuous Glucose Monitoring in Type 2 Diabetes: A Systematic Review and Meta-analysis." Diabetes Care.
- Centers for Medicare & Medicaid Services (CMS). (2025). "Clinical Laboratory Improvement Amendments (CLIA)."
- BioAgilytix. (2025). "CLIA, COLA & CAP: What's the Difference? Navigating Regulations."
- Hasin, Y., Seldin, M., Lusis, A. (2017). "Multi-omics approaches to disease." Genome Biology.
- Pietzner, M., et al. (2021). "Multi-omics integration in biomedical research—A metabolomics-centric review." Analytica Chimica Acta.
- Ahadi, S., et al. (2023). "Multi-omics microsampling for the profiling of lifestyle-associated changes in health." Nature Biomedical Engineering.
At Superpower, we test the following biomarkers:
- Immune System Biomarkers: White Blood Cells (WBC), Eosinophils, Absolute, Lymphocytes, Absolute, Lymphocytes, Basophils, Absolute, Monocytes, Absolute, Neutrophils, Monocytes, Eosinophils, Basophils, Neutrophils, Absolute, Lymphocyte-to-Monocyte Ratio (LMR), Platelet-to-WBC Ratio, Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio (MLR), Neutrophil-to-Lymphocyte & Platelet Ratio (NLPR).
- Body Composition Biomarkers: Insulin-Like Growth Factor 1 (IGF-1).
- DNA Health Biomarkers: Vitamin B12, Homocysteine, Folate.
- Thyroid Health Biomarkers: Free T4 Index (T7), Thyroid-Stimulating Hormone (TSH), T3 Uptake, Thyroxine (T4), Total, Thyroid Peroxidase Antibodies (TPO), Thyroglobulin Antibodies, Triiodothyronine (T3), Free.
- Energy Biomarkers: Ferritin, Cortisol, Total Iron Binding Capacity (TIBC), Iron Saturation, Iron, Total.
- Nutrients Biomarkers: Hemoglobin, Mean Corpuscular Hemoglobin (MCH), Hematocrit, Red Blood Cells (RBC), Mean Corpuscular Volume (MCV), Mean Corpuscular Hemoglobin Concentration (MCHC), Platelet Count, Red Cell Distribution Width (RDW), Mean Platelet Volume (MPV), Protein, Total, Vitamin D, 25-Hydroxy, RDW / MCV Ratio.
- Inflammation Biomarkers: High-Sensitivity C-Reactive Protein (hs-CRP), Erythrocyte Sedimentation Rate (ESR), Systemic Immune-Inflammation Index (SII), Ferritin-to-Albumin Ratio (FAR), Monocyte-to-HDL Ratio (MHR), CRP / Albumin Ratio (CAR), Platelet-to-Lymphocyte Ratio, Systemic Inflammation Response Index (SIRI).
- Sex Hormones Biomarkers: Testosterone, Total, Sex Hormone Binding Globulin (SHBG), Testosterone, Bioavailable, DHEA Sulfate (DHEA-S), Testosterone, Free, Estradiol, Follicle Stimulating Hormone (FSH), Prostate Specific Antigen (PSA), Free, Progesterone, Prostate Specific Antigen (PSA), Total, Luteinizing Hormone (LH), Prolactin, Free Androgen Index (FAI), Testosterone / Estradiol (T:E2).
- Metabolic Health Biomarkers: Glucose, Hemoglobin A1c (HbA1c), Estimated Average Glucose (mmol/L), Estimated Average Glucose (mg/dL), Uric Acid, Insulin, Corrected Calcium (Albumin-adjusted), (Triglyceride - Glucose Index) - TyG Index.
- Liver Health Biomarkers: Alkaline Phosphatase (ALP), Albumin/Globulin Ratio, Albumin, Alanine Aminotransferase (ALT), Bilirubin, Total, Globulin, Aspartate Aminotransferase (AST), Gamma-Glutamyl Transferase (GGT), Bilirubin, Direct, Bilirubin, Indirect, GGT-to-HDL Cholesterol Ratio (GGT / HDL-C), Indirect-to-Direct Bilirubin Ratio (I/D Bilirubin Ratio), Bilirubin-to-Albumin Ratio (BAR).
- Kidney Health Biomarkers: BUN/Creatinine Ratio, Calcium, Potassium, Carbon Dioxide (CO2), Creatinine, Chloride, Sodium, Estimated Glomerular Filtration Rate (eGFR), Blood Urea Nitrogen (BUN).
- Heart & Vascular Health Biomarkers:Non-HDL Cholesterol, HDL Cholesterol, Triglycerides, LDL Cholesterol, Cholesterol/HDL Ratio, LDL/HDL Ratio, Cholesterol, Total, Apolipoprotein B (ApoB), Lipoprotein (a), LDL P, Neutrophil-to-HDL Cholesterol Ratio (NHR), Triglyceride / HDL Cholesterol (Molar Ratio), Atherogenic Index of Plasma (AIP), Small LDL P, Non-HDL Cholesterol / Total Cholesterol (Mass Ratio), HDL Size, Large HDL P, LDL Size, Large VLDL P, Atherogenic Coefficient, LDL Cholesterol / Total Cholesterol (Mass Ratio), HDL P, VLDL Size, LDL-C / ApoB, Uric Acid / HDL-C, TG / ApoB, Non-HDL Cholesterol / Apolipoprotein B (Non-HDL-C / ApoB).